1. Home
  2. MCRB vs HTLM Comparison

MCRB vs HTLM Comparison

Compare MCRB & HTLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCRB
  • HTLM
  • Stock Information
  • Founded
  • MCRB 2010
  • HTLM 2014
  • Country
  • MCRB United States
  • HTLM Singapore
  • Employees
  • MCRB N/A
  • HTLM N/A
  • Industry
  • MCRB Biotechnology: Pharmaceutical Preparations
  • HTLM
  • Sector
  • MCRB Health Care
  • HTLM
  • Exchange
  • MCRB Nasdaq
  • HTLM NYSE
  • Market Cap
  • MCRB 72.0M
  • HTLM 58.8M
  • IPO Year
  • MCRB 2015
  • HTLM 2024
  • Fundamental
  • Price
  • MCRB $7.05
  • HTLM $3.68
  • Analyst Decision
  • MCRB Hold
  • HTLM
  • Analyst Count
  • MCRB 5
  • HTLM 0
  • Target Price
  • MCRB $73.67
  • HTLM N/A
  • AVG Volume (30 Days)
  • MCRB 93.5K
  • HTLM 22.2K
  • Earning Date
  • MCRB 05-07-2025
  • HTLM 04-07-2025
  • Dividend Yield
  • MCRB N/A
  • HTLM N/A
  • EPS Growth
  • MCRB N/A
  • HTLM N/A
  • EPS
  • MCRB 8.98
  • HTLM N/A
  • Revenue
  • MCRB N/A
  • HTLM N/A
  • Revenue This Year
  • MCRB N/A
  • HTLM N/A
  • Revenue Next Year
  • MCRB N/A
  • HTLM N/A
  • P/E Ratio
  • MCRB $0.84
  • HTLM N/A
  • Revenue Growth
  • MCRB N/A
  • HTLM N/A
  • 52 Week Low
  • MCRB $6.53
  • HTLM $2.57
  • 52 Week High
  • MCRB $30.60
  • HTLM $13.74
  • Technical
  • Relative Strength Index (RSI)
  • MCRB 38.95
  • HTLM N/A
  • Support Level
  • MCRB $7.32
  • HTLM N/A
  • Resistance Level
  • MCRB $7.86
  • HTLM N/A
  • Average True Range (ATR)
  • MCRB 0.63
  • HTLM 0.00
  • MACD
  • MCRB 0.10
  • HTLM 0.00
  • Stochastic Oscillator
  • MCRB 28.89
  • HTLM 0.00

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About HTLM HOMESTOLIFE LTD

Homestolife Ltd is a home furniture retailers that offers and sells customized furniture solutions in Singapore. It has six retail store locations that sell furniture manufactured from China and other Asian countries.

Share on Social Networks: